Search | IOVS | ARVO Journals

View

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Outcomes after Descemet Membrane Endothelial Keratoplasty (DMEK) in a German multicenter study

Klara Charlotte Borgardts; Kristina Spaniol; Björn Bachmann; Martin Hellmich; Gerd Geerling; Philip Maier; Peter MH Wiedemann; Karl Ulrich Bartz-Schmidt; Max Pattmoeller; Anna-Karina Maier-Wenzel

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2224. doi:

ARVO Annual Meeting Abstract July 2019

Correlation Between Blood Pressure, Oxygen Saturation and Macular Perfusion Measured by OCT Angiography

Matus Rehak; Anne Sophie Sauer Sauer; Catharina Busch; Peter MH Wiedemann

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3062. doi:

ARVO Annual Meeting Abstract July 2018

Predictors for very Long time visual outcome in macular edema secondary to retinal vein occlusion treated in real-world setting

Matus Rehak; Catharina Busch; Pia-Sophie Lamprecht; Peter MH Wiedemann

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2568. doi:

ARVO Annual Meeting Abstract June 2017

Re-injections of Ranibizumab by first presence of intraretinal fluid do not improve the final BCVA when compared with re-injections given by recurrence of macular edema in patients with BRVO

Matus Rehak; Maria Tuisl; Annegret Franke; Peter MH Wiedemann

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1558. doi:

ARVO Annual Meeting Abstract June 2017

OCT Characteristics Among Subjects Implanted with the Argus II Retinal Prosthesis System; the Argus II OCT Study Group

Catherine Hoeppner; Natalia F Callaway; Ninel Gregori; Byron L Lam; Hossein Ameri; Albert J Augustin; Allen Ho; Raymond Iezzi; Thiran Jayasundera; Gregg Kokame; Jennifer I Lim; Peter Szurman; Lejla Vajzovic; Peter MH Wiedemann; Jiong Yan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4267. doi:

ARVO Annual Meeting Abstract June 2017

Real life evidence data on intravitreal usage of/treatment with intravitreal aflibercept in Germany: 12-months results of an observational study in nAMD (PERSEUS)

Nicole Eter; Claudia Jochmann; Peter MH Wiedemann; Joachim Wachtlin; Helmut G Sachs; Harald Schilling; Zoran Hasanbasic; Carsten Framme

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):432. doi:

ARVO Annual Meeting Abstract September 2016

Prevalence of refractive errors in a large German cohort of children and adolescents

Heike Lange; Mandy Vogel; Arne Ohlendorf; Siegfried Wahl; Peter MH Wiedemann; Wieland Kiess; Franziska G Rauscher

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3974. doi:

ARVO Annual Meeting Abstract September 2016

Prevalence of myopia and astigmatism in adults in Germany

Arne Ohlendorf; Heike Lange; Mandy Vogel; Siegfried Wahl; Peter MH Wiedemann; Wieland Kiess; Franziska G Rauscher

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3979. doi:

ARVO Annual Meeting Abstract September 2016

Laser Peripheral Iridotomy changes Anterior Chamber Architecture significantly in Acute Angle Closure

Jan D Unterlauft; Peter MH Wiedemann

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5134. doi:

ARVO Annual Meeting Abstract June 2015

Long Time Benefit of Additional Laser Photocoagulation in Peripheral Zones of Nonperfusion in Patients with Central Retinal Vein Occlusion Treated with Ranibizumab

Matus Rehak; Annegret Franke; Maria Tuisl; Peter MH Wiedemann

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3756. doi:

ARVO Annual Meeting Abstract June 2015

Pigment Epithelium-Derived Factor of Glial Origin enhances Survival of Retinal Ganglion Cells

Jan D Unterlauft; Helena Savkovic-Cvijic; Peter MH Wiedemann; Wolfram Eichler

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5835. doi:

ARVO Annual Meeting Abstract April 2014

The Prognostic Role of Microcystic Macular Changes in Patients with Retinal Vein Occlusions Treated with Ranibizumab

Matus Rehak; Maria Tuisl; Peter MH Wiedemann

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3389. doi:

Advertisement